IMA Clinical Research Manhattan — New York, New York

IMA Clinical Research Manhattan is a clinical research site located in New York, New York, United States 10036.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

IMA Clinical Research Manhattan has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Type 2 Diabetes Mellitus.

Sponsors: Eli Lilly and Company, Biomea Fusion Inc., Paradigm Biopharmaceuticals Ltd..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IMA Clinical Research Manhattan?

IMA Clinical Research Manhattan has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IMA Clinical Research Manhattan conducted?

IMA Clinical Research Manhattan has 7 clinical trials on record, with 6 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Type 2 Diabetes Mellitus.

Is IMA Clinical Research Manhattan accredited by Crixeo Health?

Yes — IMA Clinical Research Manhattan holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about IMA Clinical Research Manhattan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.